J9289 Nivolumab and hyaluronidase-nvhy - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Nivolumab and hyaluronidase-nvhy

Brand Name:

OPDIVO QVANTIG

Strength:

2mg

HCPCS:

J9289

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Checkpoint Inhibitor

Minor Drug Class:

PD-1

Oral (Y/N):

No

FDA Approval Year:

2025

FDA Discontinuation Year:

CMS Effective Date:

July 9, 2025

CMS Discontinuation Date:

Status:

In Use